Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T9ZO
|
|||
| Drug Name |
PMID26924192-Compound-55
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BAYER PHARMA AKTIENGESELLSCHAFT
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H36N6O4S
|
|||
| Canonical SMILES |
CC1C(=O)N(C2=C(N1C3CCOCC3)N=C(C=C2)NC4=CC(=CC=C4)S(=O)(=O)NC5CCN(CC5)C)C
|
|||
| InChI |
1S/C26H36N6O4S/c1-18-26(33)31(3)23-7-8-24(28-25(23)32(18)21-11-15-36-16-12-21)27-20-5-4-6-22(17-20)37(34,35)29-19-9-13-30(2)14-10-19/h4-8,17-19,21,29H,9-16H2,1-3H3,(H,27,28)/t18-/m1/s1
|
|||
| InChIKey |
NYFZHTKDUXWZDU-GOSISDBHSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bromodomain and extraterminal domain protein (BET) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Bromodomain and extraterminal domain protein (BET) | Target's Patent Info | [1] | |
| KEGG Pathway | SNARE interactions in vesicular transport | |||
| Reactome | COPII (Coat Protein 2) Mediated Vesicle Transport | |||
| WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
| miR-targeted genes in muscle cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.